Well it appears GTG is starting to rumble again so thought I'd have a brief study of the financials. It appears that GTGs current loss per quarter is around $2mill. They have $11mill in the bank so assuming similar cashburn and revenue they really should have no need to go back to market for funding for at least another year. That would therefore be viewed as a positive by speculative investors. However, can we assume that revenues should continue increasing? I know they are receiving money out of settlements with companies for infringements, I guess that revenue is an unknown and would move around alot from quarter to quarter. But how much is this BrevanGen worth in potential revenues? Could it's revenue quickly cover the quarterly cashburn of over $3mill a quarter? Currently the marketcap is around $74mill (excluding US listing figure...how much is that to markecap?). That's a pretty reasonable marketcap for a non profitable organisation. I guess then it's ability to move up from here is dependent on how quickly investors think they wil turn profitable. Any opinions on this?
It's been a hard life for past GTG shareholders but is there a light at the end of the tunnel this time around?
- Forums
- ASX - By Stock
- GTG
- future profitability
GTG
genetic technologies limited
Add to My Watchlist
0.00%
!
3.9¢

future profitability
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online